drugset / Trial / NCT00411463
Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
Phase 2/3
Completed
25 enrolled
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk therapy) for the treatment of bipolar II depression. The name of this psychotherapy is Interpersonal and Social Rhythm Therapy for Bipolar II Depression (IPSRT-BPII). Subjects will be randomly assigned to receive either IPSRT-BPII or the medication Seroquel (quetiapine) to manage their symptoms of bipolar II depression. Subjects will receive the assigned therapy for up to 20 weeks.
Timeline
- Start
- 2006-12
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 100 mg | — |